1.
The neonatal window of opportunity-early priming for life.
Renz, H, Adkins, BD, Bartfeld, S, Blumberg, RS, Farber, DL, Garssen, J, Ghazal, P, Hackam, DJ, Marsland, BJ, McCoy, KD, et al
The Journal of allergy and clinical immunology. 2018;(4):1212-1214
-
-
Free full text
-
Abstract
The concept of the neonatal window of opportunity assigns the early postnatal period a critical role for lifelong host-microbial and immune homeostasis. It is supported by epidemiological evidence that links postnatal environmental exposure with disease susceptibility and mechanisms in the neonate host that facilitate the postnatal transposition, establish a stable microbiome, and promote immune maturation. During the conference on “The neonatal window of opportunity – early priming for life,” postnatal micro-biome and immune maturation, epidemiological evidence, and fundamental mechanisms were discussed to identify new targets for future preventive and interventional measures. From December 5 to 7, 2016, the Herrenhausen Conference “The neonatal window of opportunity – early priming for life” took place at Hannover, Germany, sponsored by the Volkswagen Foundation. The concept of the “neonatal window of opportunity,” that is, a critical nonredundant time frame in a newborn’s life during which environmental factors drive immune and tissue maturation and influence the susceptibility to immune-mediated and other diseases in adult life, was discussed.
2.
Consensus development for the supplementation of vitamin D in childhood and adolescence.
Hochberg, Z, Bereket, A, Davenport, M, Delemarre-Van de Waal, HA, De Schepper, J, Levine, MA, Shaw, N, Schoenau, E, van Coeverden, SC, Weisman, Y, et al
Hormone research. 2002;(1):39-51
3.
Nutrition in patients with cystic fibrosis: a European Consensus.
Sinaasappel, M, Stern, M, Littlewood, J, Wolfe, S, Steinkamp, G, Heijerman, HG, Robberecht, E, Döring, G
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2002;(2):51-75
Abstract
This document is the result of an European Consensus conference which took place in Artimino, Tuscany, Italy, in March 2001 involving 33 experts on nutrition in patients with cystic fibrosis, organised by the European Cystic Fibrosis Society, and sponsored by Axcan-Scandipharm, Baxter, Dr Falk Pharma, Fresenius, Nutricia, SHS International, Solvay Pharmaceuticals (major sponsor). The purpose of the conference was to develop a consensus document on nutrition in patients with cystic fibrosis based on current evidence.